New Agents in Treatment of Hyperkalemia: an Opportunity to Optimize Use of RAAS Inhibitors for Blood Pressure Control and Organ Protection in Patients with Chronic Kidney Disease
Crossref DOI link: https://doi.org/10.1007/s11906-016-0663-4
Published Online: 2016-05-26
Published Print: 2016-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rastogi, Anjay
Arman, Farid
Alipourfetrati, Setareh
Text and Data Mining valid from 2016-05-26
